Quest Diagnostics (QDI) Stock Statistics & Valuation Metrics

Quest Diagnostics has a market cap or net worth of CHF 23.96B. The enterprise value is CHF 31.99B.

Market Cap

CHF 23.96B

Enterprise Value

CHF 31.99B

Quest Diagnostics has 110,019,070 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

110,019,070

Owned by Insiders

0.46%

Owned by Institutions

68.46%

Quest Diagnostics’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 8.43%.

Return on Equity (ROE)

0.14

Return on Assets (ROA)

0.06

Return on Invested Capital (ROIC)

8.43%

Return on Capital Employed (ROCE)

0.11

Revenue Per Employee

193.60K

Profits Per Employee

17.40K

Employee Count

57,000

Asset Turnover

0.68

Inventory Turnover

39.75

The current PE Ratio of Quest Diagnostics is 25.50. Quest Diagnostics’s PEG ratio is 1.43.

PE Ratio

25.50

PS Ratio

2.41

PB Ratio

3.74

Price to FCF

20.77

Price to Operating Cash Flow

14.64

PEG Ratio

1.43

In the last 12 months, Quest Diagnostics had revenue of 11.04B and earned 992.00M in profits. Earnings per share was 8.87.

Revenue

11.04B

Gross Profit

3.52B

Operating Income

1.60B

Pretax Income

1.36B

Net Income

992.00M

EBITDA

2.19B

Earnings Per Share (EPS)

8.87

In the last 12 months, operating cash flow was 1.95B and capital expenditures -576.00M, giving a free cash flow of 1.38B billion.

Operating Cash Flow

1.95B

Free Cash Flow

1.38B

Free Cash Flow per Share

12.50

Quest Diagnostics pays an annual dividend of ―, resulting in a dividend yield of 1.29%

Dividend Per Share

―

Dividend Yield

1.29%

Payout Ratio

N/A

Free Cash Flow Yield

4.82%

Earnings Yield

3.96%

Beta

0.73

52-Week Price Change

17.13%

50-Day Moving Average

195.16

200-Day Moving Average

192.22

Relative Strength Index (RSI)

76.33

Average Volume (3m)

―

Quest Diagnostics upcoming earnings date is Feb 04, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 22, 2026

Next Earnings Date

Feb 04, 2027

Ex-Dividend Date

―

Quest Diagnostics as a current ratio of 1.04, with Debt / Equity ratio of 96.50%

Current Ratio

1.04

Quick Ratio

0.96

Debt to Market Cap

0.33

Net Debt to EBITDA

2.96

Interest Coverage Ratio

5.79

In the past 12 months, Quest Diagnostics has paid 314.00M in taxes.

Income Tax

314.00M

Effective Tax Rate

0.23

Quest Diagnostics EV to EBITDA ratio is 14.78, with an EV/FCF ratio of 24.76.

EV to Sales

2.87

EV to EBITDA

14.78

EV to Free Cash Flow

24.76

EV to Operating Cash Flow

17.45

Quest Diagnostics has CHF 797.00M in cash and marketable securities with CHF 6.29B in debt, giving a net cash position of -CHF 5.49B billion.

Cash & Marketable Securities

CHF 797.00M

Total Debt

CHF 6.29B

Net Cash

-CHF 5.49B

Net Cash Per Share

-CHF 49.88

Tangible Book Value Per Share

-CHF 24.68

Gross margin is 33.15%, with operating margin of 14.59%, and net profit margin of 9.53%.

Gross Margin

33.15%

Operating Margin

14.59%

Pretax Margin

12.66%

Net Profit Margin

9.53%

EBITDA Margin

19.45%

EBIT Margin

14.51%

The average price target for Quest Diagnostics is CHF 213.14, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

CHF 213.14

Price Target Upside

2.30% Downside

Analyst Consensus

Moderate Buy

Analyst Count

7

Revenue Growth Forecast

2.30%

EPS Growth Forecast

10.78%

Smart Score

6

AI Score

―